Last reviewed · How we verify

CD10367 3% Solution - Desquamated zone

Galderma R&D · Phase 2 active Small molecule

CD10367 3% Solution - Desquamated zone is a topical treatment that helps to remove the outer layer of the skin, reducing the appearance of desquamation.

CD10367 3% Solution - Desquamated zone is a topical treatment that helps to remove the outer layer of the skin, reducing the appearance of desquamation. Used for Treatment of desquamation.

At a glance

Generic nameCD10367 3% Solution - Desquamated zone
SponsorGalderma R&D
Drug classTopical keratolytic
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 2

Mechanism of action

It works by creating a chemical reaction that breaks down the bonds between skin cells, allowing for easy removal of the affected area. This process helps to reduce the appearance of desquamation and promote healthy skin regeneration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results